logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Aspirin protects against gastric cancer : Results of a case-control study from Moscow, Russia.

    Article - En anglais

    A case-control study of stomach cancer which includes 448 cases and 610 hospital controls has been conducted in Moscow, Russia.

    Information on life-style habits, such as smoking, alcohol consumption, diet, medical history and use of different medications including aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) was collected using a self-administered structured questionnaire.

    Venous blood was drawn from 361 cases and 441 controls.

    A serological test for Helicobacter pylon immunoglobulin G was performed to detect infected individuals.

    Use of aspirin and other NSAIDs was associated with protection against cancer of the stomach (OR=0.60,95% Cl 0.41-0.90).

    Analysis by subsite revealed that aspirin did not affect the risk of cancer of the gastric cardia but had a protective effect for non-cardia gastric cancer.

    The OR associated with use of aspirin adjusted for age and education for both sexes combined was 0.49 (95% Cl 0.31-0.77).

    A decrease in relative risk was statistically significant for men (OR=0.48,95% Cl 0.25-0.92) and women (OR=0.52,95% Cl 0.28-0.97).

    Controlling for major risk factors did not attenuate the reduction in risk.

    The observed associations were also present in individuals who were H. pylori immunoglobulin G-positive.

    There was no reduction in risk associated with aspirin andlor non-aspirin NSAIDs among non-infected subjects.

    Mots-clés Pascal : Tumeur maligne, Estomac, Antiinflammatoire non stéroïde, Acétylsalicylique acide, Facteur risque, Epidémiologie, Prévention, Chimioprophylaxie, Anticarcinogène, Russie, Eurasie, Homme, Salicylés, Appareil digestif pathologie, Estomac pathologie

    Mots-clés Pascal anglais : Malignant tumor, Stomach, Non steroidal antiinflammatory agent, Acetylsalicylic acid, Risk factor, Epidemiology, Prevention, Chemoprophylaxis, Anticarcinogen, Russia, Eurasia, Human, Salicylates, Digestive diseases, Gastric disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0487135

    Code Inist : 002B04E02. Création : 22/03/2000.